A toolkit developed to predict and analyze PROTAC-mediated ternary complexes using AlphaFold3 and Boltz-1.
PROTAC-Splitter is a machine learning framework designed for automated annotation of PROTAC substructures.
Predicting PROTAC protein degradation activity via machine learning.
Dated, falsifiable biotech investment predictions in targeted protein degradation — published before the event, scored after, misses included. Full methodology, rNPV models, and the prediction log.
Kymera Therapeutics is a clinical-stage biopharmaceutical company headquartered at 500 North Beacon Street in Watertown, Massachusetts, pioneering targeted protein degradation as a way to build oral small-molecule medicines against targets that conventional inhibitors cannot reach.
Add a description, image, and links to the targeted-protein-degradation topic page so that developers can more easily learn about it.
To associate your repository with the targeted-protein-degradation topic, visit your repo's landing page and select "manage topics."